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Objectives: To assess the long-term prognosis of leg ulcers. 
Design: A 5 year prospective cohort study. 
Materials: A random sample of 382 patients with open leg ulcers (foot ulcers included) treated in the community. 
Methods: Interim analyses were made at 15 months (arterial ulcers) and at 20 months (varicose ulcers). Long-term 
healing was assessed at 54 months by a postal questionnaire. Five year survival was assessed by official population 
registries. 
Results: At 54 months 212 patients (55%) were still alive, of whom 124 (58%) had healed their ulcers, 80 (38%) had 
open ulcers and eight (4%) were amputated. The healing was worst for patients with venous ulcers, only 44% had healed 
their original ulcers without recurrence. The 5 year survival was 52%, significantly lower than for age- and sex-matched 
controls (68%) (p = 0.0002). Patients with venous ulcers had a survival not significantly different from controls and 
patients with arterial or other aetiologies had a doubled risk of death. Diabetic patients had a lower survival than non- 
diabetics (p<O.05) and controls (p<O.O001), but the healing prognosis was not significantly different. 
Conclusion: Only patients with non-venous ulcers have a higher mortality than expected. The long-term healing 
prognosis for leg ulcer patients is poor and worst for patients with venous ulcers. 
Key Words: Leg ulcers; Venous insufficiency; Arterial insufficiency; Diabetes; Prospective study; Survival; Ulcer healing; 
Prognosis; Mortality. 
Introduction 
Chronic leg ulcers have a reputation for being difficult 
to heal and of having a tendency to recur. It is known 
from retrospective data that this is true especially 
for venous ulcers. 1 Clinical trials assessing various 
treatments frequently report very good short-term 
healing results 2~ but the patients often belong to se- 
lected groups. Healing of ulcers usually has been the 
endpoint in such studies. Therefore the important 
question of whether or not the ulcers stayed healed 
has rarely been assessed. Encouraging results have 
been reported as a result of establishing leg ulcer 
clinics in the U.K. 5 They achieved a healing-rate of 
about 70% at 12 weeks. However, one-third of the 
healed ulcers recurred within 1 year despite efforts 
to institute ulcer prophylaxis by use of compression 
hosiery and patient education. In the community, out- 
side clinical studies, the prognosis for unselected 
* Please address all correspondence to: Dr Olle Nelz6n, Department 
of Surgery, K~rnsjukhuset, S-541 85 SkOvde, Sweden. 
patients is likely to be less encouraging. Reliable pro- 
spective data on the "natural history" of chronic leg 
ulcers are hard to find. Little is also known about he 
survival of leg ulcer patients. 
To obtain reliable data on the long-term prognosis 
for a cohort of randomly selected patients with chronic 
lower limb ulceration a 5 year follow-up was under- 
taken. The patients were recruited from the Skaraborg 
study in 1988, 6which was a population based study 
that identified all patients receiving care from the 
health care system in a Swedish county. The aims were 
to assess leg ulcer healing, ulcer recurrence and patient 
survival, overall, and in aetiological subgroups. 
Methods 
Long-term follow-up was undertaken on a cohort of 
382 patients with open leg ulcers detected in the 
Skaraborg study. 6 The baseline study was of cross- 
sectional design: 827 patients were identified with 
current leg ulcers (foot ulcers included) known to the 
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Table 1. Leg ulcer classification according to Nelz6n et  al. 
Aetiological group Definition 
1. Venous 
2. Mixed venous and arterial 
3. Mixed arterial and venous* 
4. Arterial* 
5. Arterial and diabetes* 
6. Diabetes 
7. Traumatic 
8. Pressure 
9. Multifactorial A + V + D 
10. Other multifactorial 
11. Other single cause 
Ulcers caused by venous insufficiency or obstruction without any other causative factor present 
Ulcers of predominantly venous cause combined with detectable arterial impairment. ABPI generally 
0.7-0.9 
Ulcers of predominantly arterial cause combined with a minor venous insufficiency - usually superficial. 
ABPI generally 0.7 or lower 
Ulcers associated with arterial insufficiency only. ABPI generally 0.7 or lower 
Ulcers caused by a combination of arterial insufficiency and diabetic neuropathy - neuro-ischaemic 
ulcers. Any sign of arterial insuffÉciency (incompressible arteries included)+ neuropathy 
Ulcers caused by neuropathy or diabetes related skin disorders such as Necrobiosis lipoidica 
diabeticorum 
Pure trauma induced ulcers with no other predisposing factors present 
Pure pressure induced ulcers without any other predisposing factors present 
Combination of arterial, venous and diabetic ause, without any of the factors obviously dominating 
Other combinations ofaetiological factors with no obviously dominating factor 
Other single causes of leg ulcers such as vasculitis, skin tumours etc. 
* Can be divided into ulcers caused by critical ischaemia (ABPI<0.5) and ulcers of possible arterial cause. ABPI = ankle/brachial pressure 
index. 
health care system in Skaraborg county. Half  of these 
patients were randomly selected and offered an as- 
sessment; 92% agreed. These 382 patients were clin- 
ically examined and a non-invasive assessment of 
arterial and venous circulation was performed by use 
of bi-directional Doppler ultrasound. The arterial cir- 
culation was assessed by ankle-pressure meas- 
urements and calculations of ankle-brachial pressure 
index (ABPI). The assessment ofvenous valve function 
was performed with the patient standing with the 
examined leg relaxed and non-weight-bearing. For- 
ward flow of blood was induced by manual  com- 
pression of the calf fol lowed by release to detect reverse 
flow. Both the superficial and deep veins were ex- 
amined using this technique. Deep venous in- 
sufficiency (DVI) was defined as reflux in the popliteal 
vein. Further details regarding the assessments have 
been described previously. 7 
The aetiology for each ulcer was estimated based 
on history, clinical examination and non-invasive as- 
sessments of circulation and was classified according to 
Nelz6n et al. 7 (Table 1). In order to make the evaluation 
comprehensible the classification was simplified into 
three main groups: ulcers with a predominant  arterial 
cause (groups 3-5), a dominant venous cause (groups 
1 and 2) and ulcers of other aetiologies (groups 6-11). 
Subgroup analysis was also made for diabetes and 
deep venous involvement among patients with venous 
ulcers. In the base study approximately 60% of the 
ulcers were recurrent ulcers and the remaining first 
time ulcers. 1'7 The study was intended to be ob- 
servational and no interventions were initiated on the 
basis of performed investigations, except in four cases 
of l imb-threatening critical ischaemia. Altogether 30 
of 97 limbs with arterial ulceration were classified 
as caused by critical ischaemia 7 but only the four 
previously mentioned were not already receiving treat- 
ment. Except for patients with non-healing ulcers of 
arterial aetiology no active interventions were initiated 
through the study to change the ongoing treatment 
policy during follow-up. The basic design of the study 
and the timing of analyses is shown in Fig. 1. Interim 
analyses were performed only for patients with ulcers 
with potentially surgically curable causes i.e. arterial 
ulcers and venous ulcers due to isolated superficial 
venous insufficiency (SVI) and/or  perforating vein 
insufficiency (PVI) (Fig. 1). Patients with pre- 
dominantly venous ulcers caused by DVI were only 
assessed at long-term follow-up. 
15 month follow-up 
After 15 months of fol low-up a postal enquiry was 
made of all patients with original ulcers of a 
Baseline Venous 
study Arterial SVI/PVI 
15 20 
months months 
0 
1988 
Healing Survival 
all all 
i 
54 
months 60 
months 
1993 
Fig. 1. Study design and timing of analyses. 
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Table 2. Demographic data in aetiological subgroups and controls. 
Arterial Venous Other Controls 
n 84 206 92 382 
Sex: female/male 47/37 135/71 53/39 235/147 
(ratio) (1.3) (1.9) (1.4) (1.6) 
Age (years): median 80 77 74 77 
(range) (33-95) (39-97) (13-97) (13-97) 
predominantly arterial cause in either leg. All patients 
still alive with unhealed ulcers that had not been 
subjected to vascular surgical interventions or angio- 
graphy were offered further investigations and a vas- 
cular reconstruction if possible. Death certificates were 
reviewed for all patients who had died. All angiograms 
were re-evaluated. 
20 months follow-up 
At 20 months an inquiry was made to a selected group 
of patients with venous ulcers caused by isolated SVI/ 
PVI (varicose veins) who had seemed fit for varicose 
vein surgery, at the time of the baseline study. They 
were asked if the ulcer had healed or not and if they 
had experienced recurrent ulcers. The patients were 
also asked if they would consider undergoing a vari- 
cose vein operation, but no therapeutic interventions 
were initiated. 
Long-term follow-up 
At 54 months long-term follow-up was performed 
using a postal questionnaire which was distributed to 
all patients till alive at the time according to the official 
population registry (Skattemyndigheten i Skaraborgs 
l~in, May 1992). The questionnaire included a short 
introduction to remind the patients of the investigation 
they had undergone in 1988 and explaining the pur- 
pose of the present inquiry. They were asked to report 
their present ulcer status, healed or unhealed, and if 
they had experienced recurrent ulceration during the 
follow-up period. Thus, data on recurrence during 
follow-up were analysed retrospectively. A similar 
questionnaire was tested at the 15 months follow-up 
and all 18 patients examined with current ulcers had 
given correct answers, based on medical records, as 
had 13 patients who responded that they had no 
current ulcer. For patients unable to answer the ques- 
tionnaire, information regarding ulcer status was ob- 
tained from district nurses. Any uncertainties were 
clarified by telephone calls to the patients or their 
relatives. 
Based on the answers ulcer status was defined as: 
(1) original ulcer still unhealed; (2) original ulcer healed 
but recurrent ulcer open; (3) original ulcer healed 
without recurrences; (4) no open ulcer now but epi- 
sodes of recurrent ulceration during follow-up; (5) leg 
amputated ue to leg ulceration. 
The evaluation was performed on a patient basis 
and thus patients with bilateral ulceration and different 
aetiologies (3 patients) were allocated to the subgroup 
deemed most appropriate based on the severity of 
ulceration at the time of the base study. 
Information on 5 year survival was gained from the 
official population registry (L~nsskattemyndigheten in 
Skaraborg county). Death dates for all patients who 
died were received and the cumulative survival for 
each year of follow-up was calculated. A control popu- 
lation was chosen by a random selection of age and 
sex matched controls for each leg ulcer patient from 
the official population register of 1988. The survival 
of the controls was assessed as for the patients. The 
overall 5 year survival of leg ulcer patients was com- 
pared to that of the controls. Subgroup analysis was 
performed on the basis of initial ulcer diagnosis com- 
paring the groups venous, arterial and ulcers of other 
causes. An analysis of the outcome among diabetic 
patients compared with non-diabetic patients and con- 
trols was also performed. 
Statistics 
Comparisons of proportions was performed by Chi- 
squared analysis. The SPSS software package (SPSS 
Inc., Chicago, Ill., U.S.A.) with life-table analysis and 
Wilcoxon (Gehan) statistics was used to examine group 
differences in 5 year survival. Differences in dis- 
tributions of continuous variables were analysed by 
Wilcoxon rank sum test. The relative risk of death for 
leg ulcer patients was calculated by reference to the 5 
year mortality in the age and sex matched control 
population. Confidence intervals (CI) were calculated 
at 95% level of certainty. 
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Table 3. History of associated diseases and smoking habits in the subgroups. 
Arterial Venous Other 
n = 84 n = 206 n = 92 
Diabetes 47 (56) 18 (9) 39 (42) 
Hypertension 25 (30) 61 (30) 22 (24) 
Angina pectoris 16 (19) 30 (15) 10 (11) 
Myocardial infarction 13 (16) 18 (9) 12 (13) 
Intermittent claudication 20 (24) 22 (11) 13 (14) 
Arthritis 28 (33) 89 (43) 37 (40) 
Deep vein thrombosis 8 (10) 76 (37) 11 (12) 
Varicose veins 23 (27) 117 (57) 12 (13) 
Leg oedema 43 (51) 136 (66) 36 (39) 
History of smoking 24 (29) 49 (24) 20 (22) 
Figures indicate number of patients (per cent). 
Results 
All 382 patients were followed to death or to the end 
of follow-up and thus no patients were lost. The 
demographic data for patients entering the study are 
shown in Table 2. Associated diseases and smoking 
habits in the different subgroups are shown in Table 
3. The baseline characteristics for diabetic and non- 
diabetic patients have been described in detail pre- 
viously. 8The main difference was in sex ratio where 
females dominated among patients without diabetes, 
1.9 vs. 0.9 for diabetic patients. The age distribution 
was similar. Myocardial infarction and intermittent 
claudication were more prevalent among diabetic 
patients. 
15 months follow-up 
were managed conservatively and two were am- 
putated. All but one had significant angiographic le- 
sions (stenosis >50% or occlusion). According to death 
certificates 78% (14/18) of the deceased had died from 
vascular diseases (cardiovascular 12, cerebrovascular 
2). 
20 months follow-up 
Three patients out of 55 had died. The response rate 
was 100%. Of 52 surviving patients with original ulcers 
caused by isolated SVI, with or without additional 
PVI, 16 (31%) had open ulcers. An additional four 
(9%) reported recurrent ulcers during follow-up. Only 
17 patients (33%) would not consider undergoing vari- 
cose vein surgery. Three patients had had varicose 
vein surgery during follow-up. 
Of the 87 patients with ulcers of predominantly arterial 
origin, 18 (21%) had died of whom two had undergone 
vascular surgery. Evaluable responses were received 
from all patients alive. Three patients had additional 
ulcers in the contralateral limb which were considered 
to be venous. These patients were classified as venous 
leg ulcer patients in the long-term follow-up. Of the 
surviving patients, 29 (42%) still had open ulcers of 
whom 11 declined the offer of a vascular assessment 
and 18 were examined (Fig. 2). Six of the latter had 
already undergone a vascular surgical intervention, 10 
had an angiography, one had undergone amputation 
and one was missclassified (diabetic neuropathic 
ulcer). Five patients had no current ulcers since they 
had undergone a major leg amputation (three without 
a previous angiography) and eight had healed their 
ulcers as a result of a vascular reconstruction. Al- 
together 30 patients had undergone angiography; 19 
underwent a vascular reconstruction, three were 
scheduled for surgery, two declined operation, four 
Long-term ulcer healing 
Evaluable responses were gathered from all living 
patients. At 54 months, 212 patients were still alive of 
whom 109 (51%) had healed their original ulcer with- 
out recurrence, 15 (7%) had no current ulcer but had 
a history of recurrence, 36 (17%) had their original 
ulcer still open, 44 (21%) had ongoing recurrent ul- 
ceration and eight (4%) patients had undergone a 
major amputation. 
Of the subgroups, based on ulcer aetiology, the 
prognosis eemed worst for patients with venous ul- 
cers. Of those, 54% had healed their ulcers, with no 
recurrence in 44%. The detailed results for all sub- 
groups are shown in Table 4. A further subgroup 
analysis showed patients with venous ulcers and DVI 
to have the worst long-term result. Only 32/73 (44%) 
had healed their ulcers compared to 40/62 (64%) of 
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87 patients 
18 dead 29 current ulcer 
21% 33% 
11 17 + 1 amputated 
non-attenders other limb 
40 no ulcer 
27 healed 
31% 
8 healed following 
vascular surgery 
9% 
5 amputated 
6% 
Table 4. 
18 re-examined 
Fig. 2. Flow chart showing the outcome at 15 months of follow-up, among patients with arterial ulcers. 
Leg ulcer healing at 54 months. 
Aetiological subgroups Other subgroups 
All Arterial Venous Other Diabetes No diabetes 
n =212 n=29 n =135 n =48 n=51 n =161 
Healed ulcers 124 (58) 17 (59) 72 (54) 35 (73) 32 (63) 92 (57) 
Original 109 (51) 17 (59) 59 (44) 33 (69) 30 (59) 79 (49) 
Recurrent 15 (7) 0 (0) 13 (10) 2 (4) 2 (4) 13 (8) 
Open ulcers 80 (38) 11 (38) 59 (43) 10 (21) 16 (32) 64 (40) 
Original 36 (17) 4 (14) 29 (21) 3 (6) 6 (12) 30 (19) 
Recurrent 44 (21) 7 (24) 30 (22) 7 (15) 10 (20) 34 (21) 
Leg amputation 8 (4) 1 (3) 4 (3) 3 (6) 3 (6) 5 (3) 
Figures indicate number of patients (per cent). 
pat ients with isolated SV I /PV I  (varicose veins) (p = 
0.026) (Table 5). All four patients, wi th  original venous  
ulcers, that had undergone a major  leg amputat ion  
had DVI. Nine of the 40 patients, with isolated SVI /  
PVI, that had healed their ulcer had had var icose vein 
surgery dur ing fol low-up, as had two of the 22 patients 
with open ulcers. Thus, 18% of surv iv ing patients wi th  
"var icose ulcers" had undergone var icose vein surgery 
dur ing fol low-up. The overal l  heal ing for patients 
treated conservatively,  d isregarding patients who re- 
ceived varicose vein surgery, was  about  60% at 5 years. 
Table 5. Long-term healing in subgroups of patients with venous 
ulcers. 
DVI Isolated SVI/PVI 
n = 73 n = 62 
Healed ulcers 32 (44) 40 (64) 
Original 26 (36) 33 (53) 
Recurrent 6 (8) 7 (11) 
Open ulcers 37 (51) 22 (36) 
Original 16 (22) 13 (21) 
Recurrent 21 (29) 9 (15) 
Leg amputation 4 (5) 0 (0) 
Figures indicate number of patients (per cent). 
However ,  of those about  14% had had episodes of 
recurrent ulcerat ion dur ing fol low-up. 
Seven of the 17 pat ients with healed arterial ul- 
ceration had been subjected to a vascular  re- 
construct ion dur ing fol low-up, as had four out of 12 
with unhea led ulcers. Five of the pat ients with healed 
arterial ulcer had never  undergone vascular  surgery. 
The heal ing prognosis  for pat ients wi th  diabetes mel-  
litus (51) was  not signif icantly different f rom that of 
pat ients w i thout  diabetes (161) (59% healed wi thout  
recurrence vs. 49%, p = 0.29). 
5 year survival 
At 54 months  170/382 (45%) of pat ients had died and 
an addit ional  12 patients died dur ing the last 6 months  
of fol low-up. Thus, the overal l  5 year survival  was  
200/382 (52%), signif icantly lower than for the control 
populat ion  (68%) (p = 0.0002) (Fig. 3). The relative risk 
of death in leg ulcer pat ients was  1.5, 95%CI (1.1-1.9). 
The subgroup analysis revealed that the poor  survival  
was caused by  a higher morta l i ty  among patients with 
non-venous  ulcers (ar ter ia l+other  causes) whereas  
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Fig. 3. 5 year survival among leg ulcer patients and age and sex matched controls. Wilcoxon (Gehan) test (p = 0.0002). (©) leg ulcer 
patients; (0) controls. 
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Fig. 4. 5 year survival among aetiological subgroups of leg ulcer patients compared with controls. Wilcoxon (Gehan) test (*** p<0.001, Ns 
p=0.53). (©) controls; (0) arterial; (D) venous; ( I )  other. 
patients with venous ulcers had a survival not stat- 
istically different from the controls (63% vs. 68%, p = 
0.53) (Fig. 4). The relative risks (95% CI) of mortality 
among the subgroups were: venous 1.2 (0.8-1.6), ar- 
terial 2.0 (1.5-2.7) and other aetiologies 1.7 (1.2-2.3). 
Patients with diabetes had a lower long-term survival 
(43%) than non-diabetic patients (56%) (p<0.05) and 
the control population (68%) (p = 0.0001). 
Discussion 
Clinical reality is rarely comparable to that of reported 
clinical studies. Although they may use the re- 
commended methods of treatment, health care pro- 
fessionals may often be discouraged because their 
results are not as good as those reported. One reason 
for such a discrepancy is patient selection. This study 
was undertaken to give population based data on 
the long-term prognosis for a well-defined cohort of 
"unselected" leg ulcer patients treated in the com- 
munity. Thus, it was designed to assess the "natural 
history" of chronic leg ulcers. Admittedly this does not 
give the true natural history since almost all patients 
received some form of treatment albeit generally con- 
servative. This is the first follow-up study performed 
on a large random sample of leg ulcer patients iden- 
tified through a baseline cross-sectional population 
study. This should have minimised the risk of selection 
bias. Although data on healing and survival should 
be reliable, the data on recurrence should be in- 
terpreted with some caution as these were analysed 
retrospectively. 
It has been common to look upon leg ulceration 
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as a problem either caused by venous or arterial 
insufficiency. In reality, however, it is more com- 
plicated since additional causes exist and about one- 
third of ulcers have a mixed or multifactorial back- 
ground. 7'9 Mixed arterial and venous insufficiency are 
common in ulcerated legs 7'a° and up to 26% of legs with 
venous ulcers show a detectable arterial impairment, a 
Since there is no uniform definition of a venous a
nor arterial ulcer we choose to assess all aetiologies 
together in this present study. Our definition of an 
arterial ulcer is considerably wider than the European 
consensus definition of critical imb ischaemia (CLI). ~a 
That definition has been shown to be very narrow 12'a3 
especially with regard to leg ulcers, a4 Critical ischaemia 
is not a prerequisite for the diagnosis of an arterial 
ulcer. 7 
Having introduced a new classification of leg ulcers 7
we found it essential to look at the overall long-term 
outcome in an observational study. For ethical reasons, 
cases with CLI were offered immediate intervention 
as were patients with unhealed arterial ulcers at 15 
months of follow-up. There was no general agreement, 
at that time, to support the general use of varicose 
vein surgery in patients with venous ulcers, as 
The overall ong-term (54 months) healing was poor 
with only about half of surviving patients being free 
from open leg ulcers, without a history of recurrence. 
An additional 7% had a history of recurrent ulceration 
which had healed at follow-up but the remaining 42% 
still had open ulcers or had undergone amputation. 
In a follow-up of patients treated at a dermatology 
clinic in Sweden, 52% were reported free of ulceration 
after 3 years, a6 From a hospital-based leg ulcer clinic 
in Cardiff, Salaman reported retrospective data from 
490 patients treated uring a 2 year period. ~7 He found 
an overall healing rate of 74% after 12 months, but 37 
patients were lost to follow-up. The patients in that 
study were selected and as healing was the endpoint 
no information on recurrent ulceration was given. 
Apart from these studies, there are no published ata 
to compare our overall results, since they were based 
on patients with leg ulcers of all causes. 
Looking at aetiological subgroups, patients with 
venous ulcers seemed to have the worst prognosis 
with only 44% healed without history of recurrent 
ulceration after nearly 5 years. A total of 76% (102) 
had healed their original venous ulcer but 43 patients 
experienced recurrent ulceration (Table 4). These fig- 
ures are similar to the results in the frequently reported 
"Riverside study", 5where 81% of venous ulcers were 
healed within 6 months with a four layer bandage in 
special eg ulcer clinics. In the retrospective study from 
Cardiff the 12 months healing rate was 72% for venous 
ulcers, a7 We did not monitor the time to primary 
healing but it is likely that it was considerably onger 
than in Riverside. In the long-term view, however, the 
results seem to agree. 
We found it more important to assess the frequency 
of recurrent ulceration over time, since prevention of 
recurrence isat least as important as achieving primary 
healing. If a newly healed ulcer soon recurs, little 
benefit is gained. Our finding that 42% of venous 
ulcers that healed recurred is slightly worse than that 
reported within 1 year in the Riverside Study (one 
third) and worse than the 5 year recurrence rate (29%) 
in patients who used compression hosiery in a retro- 
spective study by Mayberry et al. 18 A 30% rate of 
recurrence was also found in a prospective 5 year 
study of patients with newly healed venous ulcers. 19 
Other authors have reported even higher rates of 
recurrence, a6'2°'21 The risk of recurrent venous ulceration 
is dependent on the nature of the underlying venous 
pathology and on patient compliance to wear com- 
pression hosiery once the ulcer is healed, aS"~9'2a The 
presence of DVI is a risk factor for poor healing 22 as 
well as recurrence 23 which our results support (Table 
5). Although the long-term prognosis for patients with 
ulcers caused by isolated SVI/PVI was better, 21% still 
had their original ulcer open at 54 months and 26% 
had experienced episodes of recurrence, of which more 
than half were open at the end of follow-up. The 5 
year healing, among patients with "varicose ulcers" 
treated conservatively, was only about 60%. This em- 
phasises the need for varicose and perforating vein 
surgery to improve ulcer healing and to reduce the 
risk of recurrence. 1'7'24"2s 
The long-term healing prognosis for patients with 
arterial ulcers might seem unexpectedly good from 
our results (Table 4). There are reasons for this. First 
only one-third of these patients urvived throughout 
follow-up. Secondly, only about one-third had CLI 
according to the European consensus definition, aa 
Thirdly, active intervention with vascular re- 
construction was performed. Of the 29 patients ur- 
viving throughout follow-up 11 had undergone 
vascular surgical procedures. Considering both sur- 
vival and healing prognosis the overall long-term 
prognosis was less favourable. This was also true for 
patients with ulcers of other aetiologies than arterial 
or venous. It has been indicated that patients with 
ulcers of mixed arterial and venous aetiology and 
patients with multifactorial u cers (arterial + venous + 
diabetic ause) have a worse healing prognosis 26 which 
is in line with our results. 
A substantial mortality in the cohort was expected 
as a result of the high median age at the time of 
Eur J Vasc Endovasc Surg Vol 13, May 1997 
Natural History of Leg Ulcers 507 
inclusion (77 years). The 48% 5 year mortality among 
leg ulcer patients was significantly higher than the 
32% found in the age and sex matched control group. 
This validated the findings in a previous Swedish 
study 16 which also indicated a higher cardiovascular 
mortality among leg ulcer patients. However, sub- 
group analysis showed that patients with venous ul- 
cers had an equal life expectancy as the control 
population and that patients with non-venous ulcers 
(arterial + ulcers of other causes) were responsible for 
the lower survival. The prevalence of cardiovascular 
disease and diabetes was higher among patients with 
non-venous ulcers. One-fifth of patients with arterial 
ulcers had already died within 15 months of follow- 
up mainly due to cardiovascular disease (according to 
death certificates). This is similar to the expected 1 
year mortality, of about 20%, among patients with 
CLI,  I1'I3'27 although only one-third of our patients met 
the criteria of CLI. Patients with diabetes had a sig- 
nificantly higher long-term mortality than the controls. 
Although the groups had a similar age distribution 
the sex ratios differed. This may explain some, but not 
all, of the observed ifference in survival. 
It is reasonable to believe that the higher mortality, 
among patients with non-venous ulcers, was in part 
caused by a higher prevalence of associated iseases. 
Reliable data showing an increased risk of cardio- 
vascular deaths among people with claudication has 
recently been reported. 2sHowever, others have shown 
that peripheral arterial disease is an independent risk 
factor for early death. 29 There are also indications 
that vascular surgical reconstruction might prolong 
survival in patients with CLI. 27 Such a trend might 
also exist among patients with less severe ischaemia 
and lower limb ulceration. 
Apart from the few interventions, this was an ob- 
servational study monitoring the long-term success of 
leg ulcer treatment in general in the community. We 
believe that these results give a good estimate of 
the "natural history" of chronic leg ulcers receiving 
standard treatment in an unselected population. It 
seems possible to improve these results by optimising 
leg ulcer management and to initiate measures to 
reduce the risk of recurrence. Since good compliance 
with compression hosiery is difficult o achieve 5'3° more 
efforts to improve patient education is necessary. 
Patients with potentially curable causes, such as vari- 
cose veins, insufficient perforating veins and arterial 
insufficiency should be considered for early surgical 
intervention. Efforts to improve the general awareness 
of the problem and educational efforts among health 
care professionals will hopefully improve the long- 
term prognosis for leg ulcer patients in the future. 
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